888 related articles for article (PubMed ID: 27923446)
1. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.
Huh JH; Kim KJ; Kim SU; Han SH; Han KH; Cha BS; Chung CH; Lee BW
Metabolism; 2017 Jan; 66():23-31. PubMed ID: 27923446
[TBL] [Abstract][Full Text] [Related]
2. Less liver fibrosis in metabolically healthy compared with metabolically unhealthy obese patients with non-alcoholic fatty liver disease.
Gutiérrez-Grobe Y; Juárez-Hernández E; Sánchez-Jiménez BA; Uribe-Ramos MH; Ramos-Ostos MH; Uribe M; Chávez-Tapia NC
Diabetes Metab; 2017 Sep; 43(4):332-337. PubMed ID: 28318912
[TBL] [Abstract][Full Text] [Related]
3. Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study.
Demir M; Deyneli O; Yılmaz Y
Turk J Gastroenterol; 2019 Mar; 30(3):266-270. PubMed ID: 30411703
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
[TBL] [Abstract][Full Text] [Related]
5. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
6. Obesity and Metabolic Unhealthiness Have Different Effects on Colorectal Neoplasms.
Ko SH; Baeg MK; Ko SY; Jung HS; Kim P; Choi MG
J Clin Endocrinol Metab; 2017 Aug; 102(8):2762-2769. PubMed ID: 28510711
[TBL] [Abstract][Full Text] [Related]
7. Association between obese phenotypes and risk of carotid artery plaque among chinese male railway drivers.
Pan J; Wang Z; Dong C; Yang B; Tang L; Jia P; Yang S; Zeng H
BMC Public Health; 2022 Oct; 22(1):1859. PubMed ID: 36199053
[TBL] [Abstract][Full Text] [Related]
8. Obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver disease.
Huh JH; Kim KJ; Kim SU; Cha BS; Lee BW
Hepatobiliary Pancreat Dis Int; 2022 Jun; 21(3):241-247. PubMed ID: 35365418
[TBL] [Abstract][Full Text] [Related]
9. Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?
Pongpit J; Porntharukchareon S; Kaewduang P; Promson K; Stitchantrakul W; Petraksa S; Thakkinstian A; Kositchaiwat C; Rajatanavin N; Sobhonslidsuk A
Biomed Res Int; 2016; 2016():7963972. PubMed ID: 27006950
[TBL] [Abstract][Full Text] [Related]
10. Metabolically healthy obesity and risk of non-alcoholic fatty liver disease severity independent of visceral fat.
Chen TP; Lin WY; Chiang CH; Shen TH; Huang KC; Yang KC
J Gastroenterol Hepatol; 2021 Oct; 36(10):2903-2910. PubMed ID: 33973273
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Prognosis of Acute Myocardial Infarction Associated With Metabolic Health and Obesity Status.
Chew NWS; Kong G; Venisha S; Chin YH; Ng CH; Muthiah M; Khoo CM; Chai P; Kong W; Poh KK; Foo R; Yeo TC; Chan MY; Loh PH
Endocr Pract; 2022 Aug; 28(8):802-810. PubMed ID: 35654337
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Health Is More Important than Obesity in the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Retrospective Study.
Lee MK; Rhee EJ; Kim MC; Moon BS; Lee JI; Song YS; Han EN; Lee HS; Son Y; Park SE; Park CY; Oh KW; Park SW; Lee WY
Endocrinol Metab (Seoul); 2015 Dec; 30(4):522-30. PubMed ID: 26394730
[TBL] [Abstract][Full Text] [Related]
13. Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?
Mikolasevic I; Orlic L; Franjic N; Hauser G; Stimac D; Milic S
World J Gastroenterol; 2016 Aug; 22(32):7236-51. PubMed ID: 27621571
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity.
Lonardo A; Mantovani A; Lugari S; Targher G
Ann Hepatol; 2020; 19(4):359-366. PubMed ID: 32349939
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Metabolic Health and Obesity on Subclinical Target Organ Damage.
Lee HJ; Kim HL; Chung J; Lim WH; Seo JB; Kim SH; Zo JH; Kim MA
Metab Syndr Relat Disord; 2018 Feb; 16(1):46-53. PubMed ID: 29319402
[TBL] [Abstract][Full Text] [Related]
16. Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques.
Karlas T; Berger J; Garnov N; Lindner F; Busse H; Linder N; Schaudinn A; Relke B; Chakaroun R; Tröltzsch M; Wiegand J; Keim V
World J Gastroenterol; 2015 Apr; 21(16):4894-902. PubMed ID: 25945002
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population.
Petta S; Di Marco V; Pipitone RM; Grimaudo S; Buscemi C; Craxì A; Buscemi S
Liver Int; 2018 Nov; 38(11):2060-2068. PubMed ID: 29577560
[TBL] [Abstract][Full Text] [Related]
18. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
Lai LL; Wan Yusoff WNI; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
J Gastroenterol Hepatol; 2019 Aug; 34(8):1396-1403. PubMed ID: 30551263
[TBL] [Abstract][Full Text] [Related]
19. Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis.
Sung KC; Cha SC; Sung JW; So MS; Byrne CD
Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):256-62. PubMed ID: 24361070
[TBL] [Abstract][Full Text] [Related]
20. Obesity increases the risk of erosive esophagitis but metabolic unhealthiness alone does not: a large-scale cross-sectional study.
Baeg MK; Ko SH; Ko SY; Jung HS; Choi MG
BMC Gastroenterol; 2018 Jun; 18(1):82. PubMed ID: 29884133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
